https://www.imarcgroup.com/pompe-disease-treatment-market

POMPE DISEASE TREATMENT MARKET INDUSTRY SIZE, SHARE & REPORT 2023-2028

Healthcare

Pompe Disease Treatment Market Overview 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Pompe Disease Treatment: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Pompe disease treatment share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global Pompe disease treatment market size reached US$ 1.01 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.20 Billion by 2028, exhibiting a growth rate (CAGR) of 3.0% during 2023-2028. The increasing number of clinical studies and trials, the rising popularity of ERT, and the growing number of patients suffering from Pompe disease represent some of the key factors driving the market.

Pompe disease represents a genetic disorder caused by the buildup of complex sugar, also called glycogen, in the cells, which affects organs, tissues, and muscles. It is an autosomal recessive glycogen storage syndrome that occurs, owing to the deficiency of lysosomal enzyme acid a-glucosidase (GAA). Pompe disease is associated with weak muscles, enlarged liver, trouble breathing, hearing problem, lung infection, irregular heartbeat, losing weight, etc. It is diagnosed by using various tools and tests, including electromyography, X-rays, magnetic resonance imaging (MRI), etc. Consequently, pompe disease can be treated by utilizing medications, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), injections, etc., which aid in improving the quality of life

Pompe Disease Treatment Market Trends and Drivers:

The primary driver behind the growth of the Pompe disease treatment market is the increasing prevalence of genetic abnormalities. This is further supported by the growing concerns among parents regarding the health of their newborns. Additionally, the expanding geriatric population, who are more susceptible to developing medical disorders, is also contributing significantly to market growth. Furthermore, the market is being catalyzed by the rising number of clinical studies and trials aimed at introducing new treatments. The popularity of treatments such as stem cell transplant, bone marrow transplantation, chemotherapy, and immunotherapy is also playing a crucial role in propelling the global market due to their numerous advantages. Moreover, the launch of favorable policies by government bodies and NGOs, along with continuous improvements in diagnostic technologies, are expected to further fuel the Pompe disease treatment market during the forecasted period.

Global Pompe Disease Treatment Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Amicus Therapeutics Inc., Audentes Therapeutics Inc. (Astellas US Holding Inc.), Oxyrane UK Limited, Sanofi S.A., Spark Therapeutics Inc, etc.

The report has segmented the market on the basis of region, treatment, route of administration, distribution channel, and indication type.

Treatment Insights:

  • Enzyme Replacement Therapy (ERT)
  • Substrate Reduction Therapy (SRT)
  • Chaperone-Advanced Replacement Therapy (CART)
  • Others

The report has provided a detailed breakup and analysis of the Pompe disease treatment market based on the treatment. This includes enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), and others. According to the report, enzyme replacement therapy (ERT) represented the largest segment.

Route 0f Administration Insights:

  • Oral
  • Intravenous
  • Others

A detailed breakup and analysis of the Pompe disease treatment market based on the route of administration has also been provided in the report. This includes oral, intravenous, and others.

Distribution Channel Insights:

  • Hospital and Clinics Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

A detailed breakup and analysis of the Pompe disease treatment market based on the distribution channel has also been provided in the report. This includes hospital and clinics, retail, and online pharmacies, and others. According to the report, hospital and clinics pharmacies accounted for the largest market share.

Indication Type Insights:

  • Infantile-Onset Pompe Disease (IOPD)
  • Classic Infantile Form
  • Non-Classic Infantile Form
  • Late-Onset Pompe Disease (LOPD)
  • Others

A detailed breakup and analysis of the Pompe disease treatment market based on the indication type has also been provided in the report. This includes infantile-onset Pompe disease (IOPD), classic infantile form, non-classic infantile form, late-onset Pompe disease (LOPD), and others. According to the report, late-onset Pompe disease (LOPD) accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Pompe disease treatment. Some of the factors driving the North America Pompe disease treatment market included the growing awareness about various alternative treatments, increasing number of clinical studies and trials, and well-established healthcare facilities.

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply